INVEGA
paliperidone
- Strength
- 9 mg/1
- Form
- Tablet, Extended Release
- Class
- Atypical Antipsychotic
Janssen Pharmaceuticals, Inc.
Listed by Tris Pharma Inc
| Dosage form | Tablet, Extended Release |
|---|---|
| Route | Oral |
| Drug class | Atypical Antipsychotic |
| Approval route | ANDA — approved generic |
| NDC code | 27808-222 |
| FDA application | ANDA212807 |
| RxNorm concept | 672567 |
| Package sizes listed | 1 |
| Marketed since | October 2020 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
paliperidone
Janssen Pharmaceuticals, Inc.
paliperidone
Janssen Pharmaceuticals, Inc.
paliperidone
Janssen Pharmaceuticals, Inc.
paliperidone
Janssen Pharmaceuticals, Inc.
Bryant Ranch Prepack
Eskayef Pharmaceuticals Limited
Archis Pharma LLC
Archis Pharma LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.